| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | Jul 3, 2025 | PMV Pharmaceuticals, Inc. | Chief Development Officer | Sell | 26.3 | -33,065 | -26.88% | ✗ | $35.2K |
| Sep 11, 2024 | Sep 12, 2024 | PMV Pharmaceuticals, Inc. | Chief Development Officer | Sell | 26.3 | -7,218 | -5.75% | ✗ | $10.9K |
| Sep 15, 2023 | Sep 18, 2023 | PMV Pharmaceuticals, Inc. | Chief Development Officer | Sell | 26.3 | -4,104 | -12.05% | ✗ | $27.2K |
| Aug 17, 2021 | Aug 18, 2021 | PMV Pharmaceuticals, Inc. | SVP, Regulatory Affairs and QA | Sell | 10.0 | -2,896 | -100.00% | ✓ | $97.8K |